Suzhou Strivita Pharma Technology Co., Ltd.

— Leading Experts in DMPK, Pharmacology, and Safety services for Innovative Drug Development

Suzhou Strivita Pharma Technology Co., Ltd. is a Contract Research Organization (CRO) specializing in preclinical DMPK, Pharmacology, and Safety evaluations. We offer comprehensive pharmacokinetic (PK) research services for both small molecule drugs and biologics, supporting global biopharmaceutical companies, research institutions, and biotech startups. Based in Suzhou-one of China’s leading phamarceutical hubs-Strivita operates an IACU compliant animal facility and globally oriented technical platform and a rigorous scientific management system. We are dedicated to bridging drug discovery and clinical translation, accelerating the development of innovative therapeutics. Our technical team has extensive drug preclinical experiences